✦ LIBER ✦

ANALYSIS OF THE BLEEDING AND THROMBOEMBOLIC RISK WITH CONCOMITANT USE OF ANTIPLATELET TREATMENT IN THE AMPLIFY TRIAL

✍ Scribed by Cohen, A.; Agnelli, G.; Buller, H.R.; Chaudhuri, S.; Gallus, A.S.; Raskob, G.E.; Sanders, P.; Thompson, J.; Weitz, J.I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

D-dimer and risk of thromboembolic and b

✍ Christersson, C.; Wallentin, L.; Andersson, U.; Alexander, J. H.; Ansell, J.; De 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

COMPETING RISK OF MAJOR ADVERSE CARDIAC

✍ El-Hayek, Georges; Chatterjee, Saurav; Messerli, Franz; Benjo, Alexandre; Tamis- 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 942 KB

Resource Use and Costs of Treatment With

✍ Mark E. Patterson; William C. Grant; Seth W. Glickman; Barry M. Massie; Susan E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Dual Therapy Versus Monotherapy in the E

✍ Marmo, Riccardo; Rotondano, Gianluca; Piscopo, Roberto; Bianco, Maria A.; D'Ange 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 270 KB

Dual therapy VS. Monotherapy in the endo

✍ R. Marmo; G. Rotondano; R. Piscopo; M.A. Bianco; R. D'Angella; L. Cipolletta 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Dual antiplatelet therapy versus oral an

✍ Sambola, Antonia; Montoro, J. Bruno; del Blanco, Bruno García; Llavero, Nadia; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 203 KB